Skip to content

A comparative study of lashuna taila and narayana taila uttarbasti in the treatment of female infertility

A comparative clinical study to evaluate the efficacy of lashuna taila uttarbasti and narayana taila uttarbasti in the management of stree bandhyattava w.s.r. tubal blockage - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089222
Enrollment
30
Registered
2025-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N701- Chronic salpingitis and oophoritis

Interventions

None listed

Sponsors

State ayurvedic College and Hospital Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Married women with Age between 21 to 40 years. 2.Patient of primary and secondary infertility 3.Clinically diagnosed Patients of unilateral or bilateral tubal blockage.

Exclusion criteria

Exclusion criteria: 1.Patient with active and chronic pelvic infections. 2.Patient of any Genital organ diseases like- Uterine fibroid. Genital Prolapse Endometriosis, Adenomyosis etc. 3.Patient with history of hypdrosalpinx. 4.Women of age less than 21 and above than 40. 5.Other systemic disorders like hypertension, diabetes, tuberculosis. 6.Patient having any congenital anomalies of uterus. 7.Patient having organic pathology of uterus and adnexal like cervical carcinoma, Cervical Intraepithelial Neoplasia (CIN). And any malignant growth. 8.HIV, VDRL, HBsAg positive patient.

Design outcomes

Primary

MeasureTime frame
to evaluate the efficacy of lashuna taila and narayana taila uttarbasti in management of tubal blockage Improvement in tubal patency Timepoint: after 30 days after 30 days after 30 days after 30 days of trial

Secondary

MeasureTime frame
Conception / pregnancy rate Reduction in associated symptoms of bandhayyatavaTimepoint: after30 days after 30 days aftes 30 days after completion of trial

Countries

India

Contacts

Public ContactDr Gulafshan

State Ayurvedic College and Hospital Tulsidas marg Turiyaganj Lucknow

shashi.chd98@gmail.com8795545443

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026